15:57 Jan 17
Caplin Point Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Caplin Point Laboratories Ltd.
50/100 Medium Financial Strength
Quality28/100 Expensive Valuation
Valuation55/100 Technically Neutral
TechnicalSWOT
Strength
7
Weakness
5
Opportunity
1
Threat
0
16.77K
Market Cap (Cr)
33.98
PE Ratio
6.60
Price to Book Ratio
RSI
26.98 %
Net Profit Margin
Rating Based on 2 Analysts
Buy
50%
Hold
50%
Sell
0%
Buy
Analyst Price Target
The average price target is 2037.5 with a high estimate of 2400 and low estimate of 1675
Current 2206.25
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
